Mayne Pharma | MYX - Vertriebs- Und Verwaltungskosten

Aktienkurs
2.32
Täglich Wechseln
0.07 3.11%
Monatlich
-8.30%
Jährlich
-67.91%
Q1 Prognose
2.15




Vertriebs- Und Verwaltungskosten Veränderung Datum
Ansell USD 274.8M 7.6M 2025-12
Avita Medical AUD 19.03M 1.95M 2025-12
Cochlear AUD 449.4M 214.45M 2025-12
CSL USD 1.23B 498M 2025-12
Healius AUD 393.4M 378.35M 2024-12
Integral Diagnostics AUD 169.98M 18.73M 2024-06
Medical Developments International AUD 2.84M 4.19M 2025-12
Nanosonics AUD 53.78M 26.93M 2025-12
Polynovo AUD 17.04M 1.91M 2025-12
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 275.7M 16.51M 2025-12
Sigma Healthcare AUD 134.77M 9.73M 2024-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Telix Pharmaceuticals AUD 93.48M 1.04M 2025-12